Medical Exemptions are given to patients who may have adverse events following COVID-19 Immunization:

Severe allergic reactions or anaphylaxis following a COVID-19 vaccine, Thrombosis with thrombocytopenia syndrome (TTS)/ Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) following the COVID-19 vaccine, Myocarditis or Pericarditis following a mRNA COVID-19 vaccine, actively receiving monoclonal antibody therapy OR convalescent plasma therapy for the treatment or prevention of COVID-19, and/or serious adverse event following immunization (e.g. results in hospitalization, persisitent or significant disability/incapacity).